From: Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study
Variable | AVF creation (%), n = 28 | No AVF creation (%), n = 24 | Entire cohort (n = 52) |
---|---|---|---|
Age | 72 (62-78) | 71 (51-77) | 71.5 (59.5 - 77.5) |
Gender: Male | 21 (75%) | 16 (67%) | 37 (71%) |
Etiology of CKD | |||
Diabetes mellitus | 8 (29%) | 7 (29%) | 15 (29%) |
Hypertension | 9 (32%) | 5 (21%) | 14 (27%) |
Glomerulonephritis | 1 (4%) | 3 (13%) | 4 (8%) |
Obstruction | 1 (4%) | 2 (8%) | 3 (6%) |
Other | 9 (32%) | 7 (29%) | 16 (31%) |
Diabetes mellitus | 14 (56%) | 14 (58%) | 28 (57%) |
Hypertension | 27 (100%) | 22 (92%) | 49 (96%) |
Coronary artery disease, CAD | 5 (50%) | 5 (45%) | 10 (48%) |
Family history of CAD | 1 (9%) | 2 (18%) | 3 (14%) |
Smoker | 4 (15%) | 3 (13%) | 7 (14%) |
Peripheral vascular disease | 3 (27%) | 3 (27%) | 6 (27%) |
Dyslipidemia | 8 (62%) | 7 (58%) | 15 (60%) |
eGFR, ml/min/1.7 m2 | 15 (12-18) | 24 (19-31) | 17.5 (13 - 25) |
Laboratory variables | |||
Hemoglobin, g/L | 121 ± 14 | 121 ± 16) | 121 (15) |
Creatinine, umol/L | 343 ± 88 | 231 ± 57) | 291.54 ± 93.54 |
Urine microalbumin: creatinine ratio | 285 (80-377) | 15 (9-111) | 95.7 (11.3 - 295) |
Urine Protein: Cr ratio | 0.36 (0.10-0.49) | 0.03 (0.02-0.14) | 0.11 (0.03 - 0.38) |
Systolic blood/diastolic pressure left arm | 135 (127-153)/78(70-88) | 125 (115-148)/75 (68-83) | 131.5 (119 - 149)/76 (69 – 85) |
Mean arterial pressure | 94 (89-106) | 93 (84-101) | 94 (87.67 - 104) |
Beta blocker | 8 (29) | 3 (12) | 11 (21) |
Statin | 9 (32) | 5 (21) | 14 (27) |